Financials
- Market Capitalization 45.68 M
- Employee 14
- Founded 2017
- CEO N/A
- Website www.werewolftx.com
- Headquarter Delaware, United States
- FIGI BBG00QXQ9XK4
- Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-0.48
Fiyat/satışlar oranı
—
Related tickers
| # | Ad | Fiyat | 24s % | 7g % | 1A % | 1Y % | Piyasa Değeri | Son 7 Gün | |
|---|---|---|---|---|---|---|---|---|---|
| 4281 | TCRX TScan Therapeutics, Inc. - Common Stock | 0.75 USD | 0.00% | -5.06% | -1.32% | -58.33% | 47.63 M USD | ||
| 4293 | CELU Celularity Inc. - Class A Common Stock | 1.58 USD | -24.76% | +105.19% | +132.35% | -49.03% | 45.73 M USD | ||
| 4300 | MGX Metagenomi Therapeutics, Inc. - Common Stock | 1.19 USD | -1.65% | -4.80% | -0.83% | -17.36% | 44.95 M USD | ||
| 4302 | TVGN Tevogen Bio Holdings Inc. - Common Stock | 6.89 USD | +1.92% | +6.99% | +12.58% | +657.14% | 44.86 M USD |